Surface oncology, inc. (SURF)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Assets
Current assets:
Cash and cash equivalents

56,419

46,755

38,523

37,751

41,313

82,912

41,592

50,765

59,288

22,455

Marketable securities

33,665

58,406

73,281

88,539

98,861

75,923

-

-

-

40,854

Marketable securities

-

-

-

-

-

-

131,783

134,789

34,534

-

Restricted cash

-

-

-

-

-

-

-

-

85

85

Prepaid expenses and other current assets

3,209

2,765

2,504

3,240

4,689

5,766

4,538

8,434

7,323

7,936

Total current assets

93,293

107,926

114,308

129,530

144,863

164,601

177,913

193,988

101,230

71,330

Property and equipment, net

6,851

7,286

7,628

8,015

8,117

8,226

7,099

6,932

7,072

7,326

Operating lease right-of-use asset

29,310

14,858

15,807

16,094

16,381

-

-

-

-

-

Restricted cash

1,595

1,595

1,198

1,198

1,198

1,198

1,198

1,198

1,000

1,000

Deferred offering costs

-

-

-

-

-

-

-

-

2,705

1,784

Other assets

166

28

35

11

49

40

68

15

9

14

Total assets

131,215

131,693

138,976

154,848

170,608

174,065

186,278

202,133

112,016

81,454

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

733

3,384

1,647

2,069

3,761

3,412

4,228

2,791

6,793

3,215

Accrued expenses and other current liabilities

7,545

8,012

8,433

7,925

5,502

8,803

-

-

-

9,843

Deferred revenue - related party

-

4,916

4,236

3,572

2,433

14,610

-

-

-

9,837

Accrued expenses and other current liabilities

-

-

-

-

-

-

7,298

6,968

4,771

-

Deferred revenue - related party

-

-

-

-

-

-

15,760

14,367

12,127

-

Deferred rent

-

-

-

-

-

352

352

485

485

489

Operating lease liability

5,101

2,962

1,257

1,203

1,151

-

-

-

-

-

Total current liabilities

13,379

19,274

15,573

14,769

12,847

27,177

27,638

24,611

24,176

23,384

Deferred revenue - related party, non-current

-

33,676

34,795

35,803

37,085

39,342

-

-

-

72,268

Deferred revenue - related party, non-current

-

-

-

-

-

-

47,957

51,081

55,747

-

Deferred rent, non-current

-

-

-

-

-

4,684

4,663

4,480

4,544

4,599

Operating lease liability, non-current

29,885

16,968

19,623

19,954

20,283

-

-

-

-

-

Convertible note payable, non-current

5,285

5,109

-

-

-

-

-

-

-

-

Other liabilities

1,100

-

-

-

-

-

-

-

-

-

Total liabilities

49,649

75,027

69,991

70,526

70,215

71,203

80,258

80,172

84,467

100,251

Commitments and contingencies (Note 12)

-

-

-

-

-

-

0

0

0

-

Redeemable convertible preferred stock (Series A and A-1), $0.0001 par value; no shares authorized, issued and outstanding at December 31, 2018 and 37,100,000 shares authorized, issued and outstanding at December 31, 2017

-

-

-

-

-

-

-

-

48,528

48,517

Stockholders’ equity:
Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

-

-

Common stock, $0.0001 par value; 150,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; 28,061,197 and 27,893,337 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

3

3

3

3

3

3

3

3

-

-

Additional paid-in capital

180,418

178,155

174,485

172,908

171,390

169,784

168,278

167,040

8,314

6,877

Accumulated other comprehensive income

170

103

138

174

5

-119

-190

-233

-296

-246

Accumulated deficit

-99,025

-121,595

-105,641

-88,763

-71,005

-66,806

-62,071

-44,849

-28,997

-73,945

Total stockholders’ equity

81,566

56,666

68,985

84,322

100,393

102,862

106,020

121,961

-20,979

-67,314

Total liabilities and stockholders’ equity

131,215

131,693

138,976

154,848

170,608

174,065

186,278

202,133

112,016

81,454